Specialty Studies

Built on more than 50 years of experience, Sinclair Research offers Specialty research services to support biopharmaceutical, animal health and medical device development programs. Sinclair offers expertise in all research models and is a pioneer in miniature swine research.

Sinclair Research is unique with regards to the number of specialty studies we perform each year. These specialty designs have included immunotoxicology, United States Pharmacopeia (USP) testing, bioequivalence in animal models, PK, disease model evaluations, coagulation studies, stem cell therapy, vaccine safety, biologicals pharmacokinetics, target animal safety, neurotoxicity studies, and ocular studies.

We take pride in the consultative approach we take with our clients. We gladly spend time during teleconferences, client visits on-site, or at tradeshows to discuss the intricacies of your program. We take pride in being flexible and assisting clients at all experience levels with designing and tailoring studies which enable them to provide the needed data to continue the progress of your program.

Why partner with Sinclair Research?

As one of the largest nonclinical CROs in North America, Sinclair Research’s scientific and technical expertise can provide you with the Specialty Services you need, the data you expect, and the customer experience you deserve! Contact our team to discuss your upcoming research and meet with our scientific experts to discuss how to reach your next development milestone.

Our custom-designed Specialty Services include:

  • Immunotoxicology
  • United States Pharmacopeia (USP) testing
  • bioequivalence in animal models
  • PK/PD studies
  • Disease model evaluations
  • Coagulation studies
  • Stem cell therapy
  • Vaccine safety
  • Biologicals
  • Target animal safety
  • Neurotoxicity studies
  • Ocular studies

Need information or a quote? Get in touch!

Contact us today to learn how Sinclair Research can support your upcoming research program!

Sinclair Research Has Been Acquired By Altasciences


You have Successfully Subscribed!